Literature DB >> 16732158

Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine.

Margaret Fletcher1, John Leeming, Keith Cartwright, Adam Finn.   

Abstract

During 2003-2004, locally presenting pleural empyema cases in children increased 3-fold. Antigen analysis of empyema fluid identified Streptococcus pneumoniae in 27 of 29 cases for whom samples were available and capsular polysaccharide type 1 in 18 of these. Use of a conjugate vaccine without serotype 1 antigen would have had limited impact on this morbidity in our region.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16732158     DOI： 10.1097/01.inf.0000219535.14201.1b

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  16 in total

1.  Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7).

Authors:  Thea K Chibuk; Joan L Robinson; Dawn S Hartfield
Journal:  Eur J Pediatr       Date:  2010-04-10       Impact factor: 3.183

2.  Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.

Authors:  Jigui Yu; Douglas Salamon; Mario Marcon; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

3.  Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

Authors:  J M Jefferies; A J Smith; G F S Edwards; J McMenamin; T J Mitchell; S C Clarke
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

4.  The changing epidemiology of pneumococcal pulmonary disease in the era of the heptavalent vaccine.

Authors:  Catherine A Lexau
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

5.  Complicated parapneumonic effusion in Belgian children: increased occurrence before routine pneumococcal vaccine implementation.

Authors:  Tine Van Ackere; Marijke Proesmans; Francois Vermeulen; Dirk Van Raemdonck; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2008-05-07       Impact factor: 3.183

6.  Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.

Authors:  Mehmet Ceyhan; Yasemin Ozsurekci; Nezahat Gürler; Sengul Ozkan; Gulnar Sensoy; Nursen Belet; Mustafa Hacimustafaoglu; Solmaz Celebi; Melike Keser; Ener Cagri Dinleyici; Emre Alhan; Ali Baki; Ahmet Faik Oner; Hakan Uzun; Zafer Kurugol; Ahmet Emre Aycan; Venhar Gurbuz; Eda Karadag Oncel; Melda Celik; Aslinur Ozkaya Parlakay
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

7.  Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae.

Authors:  Sylwia Wilkosz; Lindsey A Edwards; Silvia Bielsa; Catherine Hyams; Abigail Taylor; Robert J O Davies; Geoffrey J Laurent; Rachel C Chambers; Jeremy S Brown; Y C Gary Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-01       Impact factor: 6.914

8.  Bacterial causes of empyema in children, Australia, 2007-2009.

Authors:  Roxanne E Strachan; Anita Cornelius; Gwendolyn L Gilbert; Tanya Gulliver; Andrew Martin; Tim McDonald; Gillian M Nixon; Rob Roseby; Sarath Ranganathan; Hiran Selvadurai; Greg Smith; Manuel Soto-Martinez; Sadasivam Suresh; Laurel Teoh; Kiran Thapa; Claire E Wainwright; Adam Jaffe
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

Review 9.  Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Authors:  Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani
Journal:  BMC Infect Dis       Date:  2012-09-07       Impact factor: 3.090

10.  Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.

Authors:  Batmunkh Nyambat; Paul E Kilgore; Dong Eun Yong; Dang Duc Anh; Chen-Hsun Chiu; Xuzhuang Shen; Luis Jodar; Timothy L Ng; Hans L Bock; William P Hausdorff
Journal:  BMC Infect Dis       Date:  2008-07-11       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.